This report challenges the traditional divide between momentum and value investing by demonstrating how SIA’s relative strength framework can help uncover deep-value stocks as they begin to recover. By integrating the CANSLIM model with tools like the SIA Relative Strength Advancers and Point & Figure charting, advisors may be able to shorten the typical wait time associated with traditional value strategies. Sector rotation signals, including the recent rise in the Drugs sector and Merck’s early-stage Point & Figure catapult breakout, provide timely, real-world examples of hunting tomorrow’s leaders before they become broadly recognized. Most importantly, this approach reframes opportunity cost not as an unavoidable trade-off, but as a risk that can be actively managed through disciplined, data-driven positioning.